The Associated Press reports:
Perdue’s timing was impeccable. He avoided a sharp loss and reaped a stunning gain by selling and then buying the same stock: Cardlytics, an Atlanta-based financial technology company on whose board of directors he once served.
On Jan. 23, as word spread through Congress that the coronavirus posed a major economic and public health threat, Perdue sold off $1 million to $5 million in Cardlytics stock at $86 a share before it plunged, according to congressional disclosures.
Weeks later, in March, after the company’s stock plunged further following an unexpected leadership shakeup and lower-than-forecast earnings, Perdue bought the stock back for $30 a share, investing between $200,000 and $500,000. Those shares have now quadrupled in value, closing at $121 a share on Tuesday.
Read the full article.
10 months ago today, Perdue invested in a PPE company the same day he had a private briefing on COVID. Then he dumped casino shares and purchased pharmaceutical stocks while publicly downplaying the virus.
— Georgia Democrats (@GeorgiaDemocrat) November 25, 2020
The latest in a string of stories scrambling Perdue’s financial dealings with the Cardlytics financial firm: The Georgia Republican carried out a series of well-timed stock transactions at the beginning of the coronavirus pandemic. #gapol #gasenhttps://t.co/KlZOgvOeYd
— Greg Bluestein (@bluestein) November 25, 2020